蕭裕泉醫師眼科筆記

 Anit-inflammation Perfecting cataract surgery EyeWorld Supplement to EyeWorld August 2012 Inflammation remains a significant challenge to modern cataract surgery. Left untreated, inflammation can ruin even the most consummately performed surgery utilizing the most advanced techniques and technology. Experts gathered to discuss “Ocular Anti-Inflammation: Prevention, Diagnosis, and Curative Treatment Options” at an EyeWorld Educational Symposium held at the 2012 ASCRS•ASOA Symposium & Congress. The event was supported by an educational grant from ISTA Pharmaceuticals (Irvine, Calif.). NSAID issues 2012 “Cataract surgery is evolving,” said Dr. Katsev. According to Dr. Katsev, patients’ standards have been increasing in the last decade in part thanks to the increasing role of premium IOLs in cataract surgery. In that time, the use of premium IOLs has increased dramatically, he said, but the promise of great vision these IOLs make does not necessa...

Review of "Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: Possible mechanism of intraoperative floppy-iris syndrome" -------------------------------------------------------------------------------- by Daniel L. Chao, M.D., Yasha S. Modi, M.D., Bradford Lee, M.D., Jayanth Sridhar, M.D., Ajay E. Kuriyan M.D., and Steven J. Gedde, M.D., Bascom Palmer Eye Institute, Miami, Fla. Steven J. Gedde, M.D. This month, an important paper on the mechanism of IFIS appears in JCRS. I invited the Bascom Palmer residents to review it, and their analysis will help our clinician readers to better understand the findings and their significance. —David F. Chang, M.D., EyeWorld chief medical editor The residents from Bascom Palmer Eye Institute Source: Steven J. Gedde, M.D.  Intraoperative floppy iris syndrome (IFIS) is a recently described condition that may present significant challenges during cataract surger...